Purple Biotech (PPBT) Operating Leases (2015 - 2025)
Purple Biotech's (PPBT) quarterly Operating Leases came in at $244000.0 in Q4 2025, up 33.33% year-on-year from $183000.0 in Q4 2024, and up 33.33% on a QoQ basis from $183000.0 in Q4 2024.
Purple Biotech (PPBT) Operating Leases (2015 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 11 years of Operating Leases data on file, last reported at $244000.0 in Q4 2025.
- On a quarterly basis, Operating Leases rose 33.33% year-over-year to $244000.0 in Q4 2025; TTM through Dec 2025 was $244000.0, a 33.33% increase from a year earlier, with the FY2025 full-year figure at $244000.0, up 33.33% from the prior year.
- Operating Leases for Q4 2025 stood at $244000.0, up from $183000.0 in the prior quarter.
- Over the last five years, Operating Leases for PPBT reached as high as $622000.0 in Q1 2021 and fell as low as $38000.0 in Q3 2024.
- Historically, Operating Leases has averaged $320411.8 across 5 years, with a median of $278000.0 in 2023.
- Across the five-year window, Operating Leases soared 329.08% in 2021 and plunged 80.21% in 2024, its largest moves.
- Year by year, Operating Leases stood at $550000.0 in 2021, then slumped by 41.64% to $321000.0 in 2022, then sank by 49.22% to $163000.0 in 2023, then grew by 12.27% to $183000.0 in 2024, then soared by 33.33% to $244000.0 in 2025.
- Per Business Quant data, the three most recent Operating Leases figures were $244000.0 in Q4 2025, $183000.0 in Q4 2024, and $38000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Purple Biotech | 1.33 Bn | 1.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 121,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 321,000.00 |
| Sep 30, 2022 | 357,000.00 |
| Jun 30, 2022 | 399,000.00 |
| Mar 31, 2022 | 495,000.00 |
| Dec 31, 2021 | 550,000.00 |
| Sep 30, 2021 | 563,000.00 |
| Jun 30, 2021 | 605,000.00 |
| Mar 31, 2021 | 622,000.00 |
| Dec 31, 2020 | 1.05 Mn |
| Jun 30, 2020 | 141,000.00 |
| Dec 31, 2019 | 28,000.00 |